https://coavetx.com Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS (Central Nervous System) diseases. Tue, 03 Feb 2026 14:06:20 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://coavetx.com/wp-content/uploads/2021/07/cropped-coave-tx-fav-1-1-32x32.png https://coavetx.com 32 32 https://coavetx.com/technicien-superieur-assistant-ingenieur-rd-en-bioconjugaison-2/?utm_source=rss&utm_medium=rss&utm_campaign=technicien-superieur-assistant-ingenieur-rd-en-bioconjugaison-2 Tue, 03 Feb 2026 11:23:00 +0000 https://coavetx.com/?p=6201

]]> https://coavetx.com/research-assistant-analytics/?utm_source=rss&utm_medium=rss&utm_campaign=research-assistant-analytics Tue, 20 Jan 2026 16:20:23 +0000 https://coavetx.com/?p=6945

]]> https://coavetx.com/coave-therapeutics-unveils-lead-gene-therapy-program-for-retinal-vascular-diseases-powered-by-first-in-class-vector-for-suprachoroidal-delivery/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-unveils-lead-gene-therapy-program-for-retinal-vascular-diseases-powered-by-first-in-class-vector-for-suprachoroidal-delivery Fri, 14 Nov 2025 07:58:24 +0000 https://coavetx.com/?p=6923 https://coavetx.com/coave-therapeutics-demonstratessuperiority-of-its-novel-suprachoroidal-capsidat-esgct-congress-2025/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-demonstratessuperiority-of-its-novel-suprachoroidal-capsidat-esgct-congress-2025 Tue, 07 Oct 2025 07:00:00 +0000 https://coavetx.com/?p=6748 https://coavetx.com/coave-therapeutics-establishes-new-scientific-advisory-board-to-accelerate-innovation-in-genetic-medicines-for-eye-and-cns-diseases/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-establishes-new-scientific-advisory-board-to-accelerate-innovation-in-genetic-medicines-for-eye-and-cns-diseases Tue, 20 May 2025 19:05:07 +0000 https://coavetx.com/?p=6712 https://coavetx.com/coave-therapeutics-launches-coaav-csf-01-a-novel-brain-targeted-gene-therapy-vector-for-neurodegenerative-and-other-cns-diseases/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-launches-coaav-csf-01-a-novel-brain-targeted-gene-therapy-vector-for-neurodegenerative-and-other-cns-diseases Fri, 09 May 2025 20:29:56 +0000 https://coavetx.com/?p=6686 https://coavetx.com/coave-therapeutics-expands-into-the-us-with-strategic-appointment-of-romain-pettenaro-as-vp-of-business-development/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-expands-into-the-us-with-strategic-appointment-of-romain-pettenaro-as-vp-of-business-development Wed, 23 Apr 2025 09:25:15 +0000 https://coavetx.com/?p=6664 https://coavetx.com/coave-therapeutics-to-attend-upcoming-conferences/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-to-attend-upcoming-conferences Wed, 09 Apr 2025 09:59:35 +0000 https://coavetx.com/?p=6653 https://coavetx.com/coave-therapeutics-showcases-breakthrough-in-peptide-based-conjugated-aav-vectors-using-aligater-platform-in-a-late-breaking-abstract-at-esgct-2024/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-showcases-breakthrough-in-peptide-based-conjugated-aav-vectors-using-aligater-platform-in-a-late-breaking-abstract-at-esgct-2024 Mon, 21 Oct 2024 12:36:36 +0000 https://coavetx.com/?p=6511 https://coavetx.com/coave-therapeutics-to-present-novel-data-highlighting-the-potential-of-its-aligater-platform-to-enhance-the-targeted-delivery-of-genetic-medicines-at-upcoming-conferences/?utm_source=rss&utm_medium=rss&utm_campaign=coave-therapeutics-to-present-novel-data-highlighting-the-potential-of-its-aligater-platform-to-enhance-the-targeted-delivery-of-genetic-medicines-at-upcoming-conferences Mon, 23 Sep 2024 15:35:22 +0000 https://coavetx.com/?p=6485